Middle East Pharmaceutical Industries Co. (4016)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Major Shareholders
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.0 Saudi Riyal

Market Cap 1,180,000,000.00 Saudi Riyal

Book Value (BVPS) 19.26 Saudi Riyal Based on: Second Quarter 2025

P/B Ratio 5.99 Last update: 2026-04-11

EPS 4.96 Saudi Riyal Based on: Second Quarter 2025

P/E Ratio 67.16 Last update: 2026-04-11

Trading Currency Saudi Riyal

Company Statistics

News

Avalon Pharma appoints new leadership team Management Decisions

CMA greenlights Avalon Pharma’s capital hike Company News

Avalon Pharma, Bio-Thera reach license agreements for BAT3306 in MENA Companies Investments

Avalon Pharma unveils SAR 25m cash dividends for H2-24 Board of Directors

Avalon Pharma’s board approves dividends for H1-24 Cash Dividends

Avalon Pharma obtains SAR 70m from Emirates NBD Banking and Finance

Market Announcements